|
|
|
Volumn 18, Issue 7 Suppl 4, 2004, Pages 17-28
|
|
Irinotecan in advanced lung cancer: focus on North American trials.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ANTINEOPLASTIC ANTIMETABOLITE;
CAMPTOTHECIN;
CISPLATIN;
DEOXYCYTIDINE;
DNA TOPOISOMERASE;
DRUG DERIVATIVE;
ENZYME INHIBITOR;
ETOPOSIDE;
GEMCITABINE;
IRINOTECAN;
RIBONUCLEOTIDE REDUCTASE;
TAXOID;
VINDESINE;
ADJUVANT THERAPY;
ARTICLE;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG ANTAGONISM;
HUMAN;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
NORTH AMERICA;
PHASE 3 CLINICAL TRIAL;
RANDOMIZED CONTROLLED TRIAL;
SMALL CELL CARCINOMA;
SURVIVAL RATE;
ANTIMETABOLITES, ANTINEOPLASTIC;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CAMPTOTHECIN;
CARCINOMA, NON-SMALL-CELL LUNG;
CARCINOMA, SMALL CELL;
CISPLATIN;
DEOXYCYTIDINE;
DNA TOPOISOMERASES, TYPE I;
ENZYME INHIBITORS;
ETOPOSIDE;
HUMANS;
LUNG NEOPLASMS;
NORTH AMERICA;
RADIOTHERAPY, ADJUVANT;
RIBONUCLEOTIDE REDUCTASES;
SURVIVAL RATE;
TAXOIDS;
VINDESINE;
|
|
EID: 4644362988
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (4)
|
|
References (0)
|
